Use access key #2 to skip to page content.
$8.97 0.00 (0.00%)
10/16/2008 4:00 PM

Tercica, Inc. (TRCA)

CAPS Rating:
*

A biopharmaceutical company focuses on the development and commercialization of new therapeutics for the treatment of short stature and other endocrine disorders.

View All Commentary (TRCA)

Recs

0

Avatar Tradestocky (55.32) Submitted: 3/07/07 2:05 PM : Outperform Start Price: $5.93 TRCA Score: 89.00

Drug companies seem sketchy but if you get on the bandwagon on the way up and get off at the top they leave you feeling pretty high!

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links